Detailed information for compound 183180

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 268.329 | Formula: C17H17FN2
  • H donors: 1 H acceptors: 1 LogP: 3.13 Rotable bonds: 0
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC1=CC2CC(C1)c1c(C2)nc2c(c1N)ccc(c2)F
  • InChi: 1S/C17H17FN2/c1-9-4-10-6-11(5-9)16-15(7-10)20-14-8-12(18)2-3-13(14)17(16)19/h2-4,8,10-11H,5-7H2,1H3,(H2,19,20)
  • InChiKey: CPGLYAIYMGVIIO-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens acetylcholinesterase (Yt blood group) Starlite/ChEMBL References
Bos taurus Acetylcholinesterase Starlite/ChEMBL References
Homo sapiens butyrylcholinesterase Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi Carboxylesterase family protein Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus granulosus acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus multilocularis acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) carboxylesterase Get druggable targets OG5_126875 All targets in OG5_126875
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus granulosus carboxylesterase 5A Get druggable targets OG5_126875 All targets in OG5_126875
Brugia malayi Carboxylesterase family protein Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus multilocularis carboxylesterase 5A Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus multilocularis acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875
Schistosoma japonicum Acetylcholinesterase 1 precursor, putative Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) acetylcholinesterase 1 Get druggable targets OG5_126875 All targets in OG5_126875
Schistosoma japonicum ko:K01049 acetylcholinesterase [EC3.1.1.7], putative Get druggable targets OG5_126875 All targets in OG5_126875
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_126875 All targets in OG5_126875
Echinococcus granulosus acetylcholinesterase Get druggable targets OG5_126875 All targets in OG5_126875

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Onchocerca volvulus Molybdopterin synthase catalytic subunit homolog Acetylcholinesterase   613 aa 564 aa 30.3 %
Brugia malayi Carboxylesterase family protein butyrylcholinesterase 602 aa 546 aa 30.2 %
Onchocerca volvulus Carnitine O-palmitoyltransferase 2, mitochondrial homolog Acetylcholinesterase   613 aa 511 aa 39.9 %
Echinococcus granulosus BC026374 protein S09 family Acetylcholinesterase   613 aa 627 aa 34.0 %
Echinococcus multilocularis BC026374 protein (S09 family) Acetylcholinesterase   613 aa 627 aa 33.8 %
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) Acetylcholinesterase   613 aa 601 aa 23.6 %
Onchocerca volvulus Putative nuclear protein Acetylcholinesterase   613 aa 572 aa 41.6 %
Loa Loa (eye worm) hypothetical protein Acetylcholinesterase   613 aa 573 aa 26.5 %
Onchocerca volvulus Acetylcholinesterase   613 aa 565 aa 26.0 %
Brugia malayi Carboxylesterase family protein Acetylcholinesterase   613 aa 569 aa 31.3 %
Loa Loa (eye worm) hypothetical protein Acetylcholinesterase   613 aa 561 aa 24.6 %
Drosophila melanogaster CG10175 gene product from transcript CG10175-RE Acetylcholinesterase   613 aa 527 aa 32.3 %
Brugia malayi Carboxylesterase family protein acetylcholinesterase (Yt blood group) 614 aa 510 aa 26.5 %
Onchocerca volvulus Acetylcholinesterase   613 aa 613 aa 26.8 %
Echinococcus multilocularis neuroligin Acetylcholinesterase   613 aa 534 aa 23.2 %
Onchocerca volvulus Acetylcholinesterase   613 aa 552 aa 31.3 %
Brugia malayi Carboxylesterase family protein Acetylcholinesterase   613 aa 491 aa 26.7 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Leishmania major serine/threonine-protein kinase a, putative 0.0547 0 0.5
Echinococcus granulosus Glutaredoxin protein 5 1.0342 0.6272 0.9004
Echinococcus granulosus sodium:potassium dependent atpase beta subunit 1.0342 0.6272 0.9004
Entamoeba histolytica protein kinase, putative 1.6165 1 1
Trichomonas vaginalis AGC family protein kinase 0.5392 0.3102 0.3102
Echinococcus multilocularis nervana 2 1.0342 0.6272 0.9004
Loa Loa (eye worm) AGC/AKT protein kinase 1.6165 1 1
Loa Loa (eye worm) AGC/RSK/P70 protein kinase 1.5734 0.9724 0.96
Trichomonas vaginalis serine/threonine-protein kinase sgk, putative 0.5276 0.3027 0.3027
Entamoeba histolytica PH domain containing protein kinase, putative 1.0889 0.6622 0.6622
Echinococcus multilocularis rac serine:threonine kinase 1.0889 0.6622 1
Echinococcus granulosus nervana 2 1.0342 0.6272 0.9004
Leishmania major folate/biopterin transporter, putative 0.0547 0 0.5
Trichomonas vaginalis AGC family protein kinase 0.5392 0.3102 0.3102
Trypanosoma brucei rac serine-threonine kinase, putative 1.6165 1 1
Trichomonas vaginalis AGC family protein kinase 1.6165 1 1
Trichomonas vaginalis AGC family protein kinase 1.6165 1 1
Trichomonas vaginalis AGC family protein kinase 1.6165 1 1
Trichomonas vaginalis AGC family protein kinase 1.6165 1 1
Echinococcus granulosus serine/threonine protein kinase 1.0889 0.6622 1
Trichomonas vaginalis AGC family protein kinase 1.6165 1 1
Schistosoma mansoni serine/threonine-protein kinase 1.0889 0.6622 1
Echinococcus multilocularis sodium:potassium dependent atpase beta subunit 1.0342 0.6272 0.9004
Echinococcus granulosus nervana 2 1.0342 0.6272 0.9004
Schistosoma mansoni serine/threonine-protein kinase 1.0889 0.6622 1
Leishmania major protein kinase, putative 0.0547 0 0.5
Echinococcus multilocularis nervana 2 1.0342 0.6272 0.9004
Trichomonas vaginalis AGC family protein kinase 1.6165 1 1
Trichomonas vaginalis AGC family protein kinase 0.5823 0.3378 0.3378
Entamoeba histolytica protein kinase, putative 1.6165 1 1
Giardia lamblia Kinase, AGC PKA 1.0458 0.6346 0.5
Echinococcus granulosus serine threonine protein kinase nrc 1.0458 0.6346 0.9216
Leishmania major protein kinase, putative,serine/threonine protein kinase, putative 0.0547 0 0.5
Trypanosoma cruzi Protein kinase B 1.0889 0.6622 1
Plasmodium vivax rac-beta serine/threonine protein kinase, putative 1.0458 0.6346 1
Toxoplasma gondii AGC kinase 1.5734 0.9724 1
Plasmodium falciparum RAC-beta serine/threonine protein kinase 1.0458 0.6346 1
Trypanosoma cruzi rac serine-threonine kinase, putative 1.0458 0.6346 0.9583
Trichomonas vaginalis AGC family protein kinase 1.6165 1 1
Entamoeba histolytica protein kinase, putative 0.5392 0.3102 0.3102
Leishmania major rac serine-threonine kinase, putative,protein kinase, putative 0.0547 0 0.5
Trypanosoma cruzi rac serine-threonine kinase, putative 1.0889 0.6622 1
Echinococcus multilocularis Glutaredoxin protein 5 1.0342 0.6272 0.9004
Echinococcus granulosus calcium:calmodulin dependent protein kinase 1.0458 0.6346 0.9216
Entamoeba histolytica protein kinase 2, putative 1.0458 0.6346 0.6346
Entamoeba histolytica PH domain containing protein kinase, putative 1.0889 0.6622 0.6622
Leishmania major protein kinase, putative 0.0547 0 0.5
Echinococcus multilocularis serine threonine protein kinase nrc serine threonine protein kinase gad 1.0458 0.6346 0.9216
Trichomonas vaginalis AGC family protein kinase 0.5392 0.3102 0.3102
Brugia malayi p70 ribosomal S6 kinase beta 1.5734 0.9724 0.96
Entamoeba histolytica protein kinase, putative 1.5734 0.9724 0.9724

Activities

Activity type Activity value Assay description Source Reference
AI50 (functional) = 8 Compound was evaluated for the antagonism index ChEMBL. 11101357
AI50 (functional) 0 nM Drug concentration that reaches 50% of antagonism index (AI); Not determined ChEMBL. 10464010
AI50 (functional) = 8 nM Drug concentration that reaches 50% of antagonism index (AI). ChEMBL. 10464010
AI50 (functional) = 48.6 nM Drug concentration that reaches 50% of antagonism index (AI). ChEMBL. 10464010
Fold IC50 (binding) ~ 15 Inhibitory activity of the compound against acetylcholinesterase compared to the IC50 of (-)-9M-HTH ChEMBL. 10602696
IC50 (binding) = -8.46 In vitro inhibitory activity against bovine acetylcholinesterase ChEMBL. 15317459
IC50 (binding) = 3.49 nM Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes ChEMBL. 10464010
IC50 (binding) = 3.49 nM Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes ChEMBL. 10464010
IC50 (binding) = 3.49 nM Inhibition of bovine erythrocyte AChE ChEMBL. 17154513
IC50 (binding) = 4.58 nM Inhibition of acetylcholinesterase isolated from Human erythrocytes. ChEMBL. 11101357
IC50 (binding) = 4.58 nM Inhibition of acetylcholinesterase isolated from Human erythrocytes. ChEMBL. 11101357
IC50 (binding) = 8.5 nM Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes ChEMBL. 10464010
IC50 (binding) = 8.5 nM Compound was evaluated for the inhibition of acetylcholinesterase of bovine erythrocytes ChEMBL. 11101357
IC50 (binding) = 8.5 nM Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes ChEMBL. 10464010
IC50 (binding) = 8.5 nM Compound was evaluated for the inhibition of acetylcholinesterase of bovine erythrocytes ChEMBL. 11101357
IC50 (binding) = 8.51 nM Inhibition of bovine erythrocyte AChE ChEMBL. 17154513
IC50 (binding) = 138 nM Inhibition of butyrylcholinesterase (BChE) activity in human serum ChEMBL. 10464010
IC50 (binding) = 138 nM Inhibition of butyrylcholinesterase (BChE) activity in human serum ChEMBL. 10464010
IC50 (binding) = 197 nM Inhibition of butyrylcholinesterase (BChE) activity in human serum ChEMBL. 10464010
IC50 (binding) = 197 nM Inhibition of butyrylcholinesterase (BChE) in human serum ChEMBL. 11101357
IC50 (binding) = 197 nM Inhibition of butyrylcholinesterase (BChE) activity in human serum ChEMBL. 10464010
IC50 (binding) = 197 nM Inhibition of butyrylcholinesterase (BChE) in human serum ChEMBL. 11101357
IC50 (binding) = 1480 nM Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes ChEMBL. 10464010
IC50 (binding) = 1480 nM Inhibition of acetylcholinesterase (AChE)activity in bovine erythrocytes ChEMBL. 10464010
IC50 (binding) = 2930 nM Inhibition of butyrylcholinesterase (BChE) activity in human serum ChEMBL. 10464010
IC50 (binding) = 2930 nM Inhibition of butyrylcholinesterase (BChE) activity in human serum ChEMBL. 10464010
Ratio (binding) = 1.86 Ratio between IC50 of bovine AChE and human AChE ChEMBL. 11101357
Ratio (binding) = 2 Inhibition ratio, (IC50 for human BChE activity) / (IC50 for bovine AChE activity) ChEMBL. 10464010
Ratio (binding) = 23 Inhibition ratio, (IC50 for human BChE activity) / (IC50 for bovine AChE activity) ChEMBL. 10464010
Ratio (binding) = 40 Inhibition ratio, (IC50 for human BChE activity) / (IC50 for bovine AChE activity) ChEMBL. 10464010
Ratio (binding) = 43 Ratio between IC50 of human BChE and human AChE ChEMBL. 11101357

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

3 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.